Rosuvastatin has possible interactions with alcohol, some other drugs, and certain supplements. Examples include antacids ...

AstraZeneca is to sell European rights to its cholesterol drug Crestor (rosuvastatin) to Germany’s Grunenthal. Crestor is a statin and at its peak generated annual revenues of more than $7 ...

She oversaw the launch of Crestor® and its growth into a $2 billion ... enables rapid and precise drug design through iterative molecular SNÅPshots that help predict genetic alterations most ...

CARLSBAD, Calif. - Tyra Biosciences , Inc. (NASDAQ:TYRA), a biotech firm specializing in precision medicines targeting Fibroblast Growth Factor Receptor (FGFR) biology, today announced the appointment ...

AstraZeneca has bought rights to an orally-active drug that inhibits PCSK9 ... for the company a few years back thanks to its statin Crestor (rosuvastatin), a $5 billion brand at its peak which ...

The prescribed dosage for fluoxetine may depend on a person’s individual treatment plan. Other factors, including your specific diagnosis, body weight, and medical history, may affect your ...

Sound Off is an opinion forum for Mercury readers to offer brief comments on today’s news. Submissions must be 75 words or ...

Azstarys (serdexmethylphenidate/dexmethylphenidate) is a prescription drug that’s taken to treat ADHD. The drug comes as an oral capsule that you take once per day ...

The estimate suggests a change of +45.3% year over year. Analysts predict that the 'BioPharmaceuticals- CVRM- Crestor- World' will reach $250.88 million. The estimate indicates a change of +1.6% ...